AORT Artivion Inc

USD 23.78 0.00 0
Icon

Artivion Inc (AORT) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NYE
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 23.78

0.00 (0.00)%

USD 0.99B

0.12M

USD 24.86(+4.53%)

USD 17.00 (-28.51%)

Icon

AORT

Artivion Inc (USD)
COMMON STOCK | NYE
USD 23.78
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

USD 0.99B

USD 17.00 (-28.51%)

USD 23.78

Artivion Inc (AORT) Stock Forecast

Show ratings and price targets of :
USD 24.86
(+4.53%)

Based on the Artivion Inc stock forecast from 3 analysts, the average analyst target price for Artivion Inc is USD 24.86 over the next 12 months. Artivion Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Artivion Inc is Bearish, which is based on 2 positive signals and 10 negative signals. At the last closing, Artivion Inc’s stock price was USD 23.78. Artivion Inc’s stock price has changed by +1.36% over the past week, +17.32% over the past month and +62.21% over the last year.

No recent analyst target price found for Artivion Inc
No recent average analyst rating found for Artivion Inc

Company Overview Artivion Inc

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary pro...Read More

https://artivion.com

1655 Roberts Boulevard N.W., Kennesaw, GA, United States, 30144

1,500

December

USD

USA

Adjusted Closing Price for Artivion Inc (AORT)

Loading...

Unadjusted Closing Price for Artivion Inc (AORT)

Loading...

Share Trading Volume for Artivion Inc Shares

Loading...

Compare Performance of Artivion Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AORT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Artivion Inc (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ABT
Abbott Laboratories 0.00 (0.00%) USD180.83B 32.38 18.75

ETFs Containing AORT

Symbol Name AORT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Artivion Inc (AORT) Stock

Based on ratings from 3 analysts Artivion Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 7 buy, sell and hold ratings.

Unfortunately we do not have enough data on AORT's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for AORT is USD 24.86 over the next 12 months. The maximum analyst target price is USD 30 while the minimum anlayst target price is USD 22.

AORT stock's Price/Earning ratio is 422.62. Our analysis grades AORT stock's Price / Earning ratio at F. This means that AORT stock's Price/Earning ratio is above 91% of the stocks in the Medical Devices sector in the NYE exchange. Based on this AORT may be a overvalued for its sector.

The last closing price of AORT's stock was USD 23.78.

The most recent market capitalization for AORT is USD 0.99B.

Based on targets from 3 analysts, the average taret price for AORT is projected at USD 24.86 over the next 12 months. This means that AORT's stock price may go up by +4.53% over the next 12 months.

We can't find any ETFs which contains Artivion Inc's stock.

As per our most recent records Artivion Inc has 1,500 Employees.

Artivion Inc's registered address is 1655 Roberts Boulevard N.W., Kennesaw, GA, United States, 30144. You can get more information about it from Artivion Inc's website at https://artivion.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...